Pain-Free Diagnostic Results for the Expectant Mother

At Molecular Testing Labs™, we are proud to offer Women’s Health screenings in the form of Cystic Fibrosis and Thrombosis genetic tests. Our panels are administered to expectant mothers during the early stages of pregnancy to assess the risk of complications during pregnancy.

Couple and baby.

Pregnant woman with doctor.

Cystic Fibrosis Screening

  • Cystic Fibrosis is the most common genetic disease in the United States.
  • Our panel has the most comprehensive mutation coverage. Multiplex genotyping – no reflex testing necessary.
  • Our test exceeds the American College of Obstetricians and Gynecologists (ACOG) and the American College of Medical Genetics (ACMG) recommendations for Cystic Fibrosis screening.
  • The test is administered by a buccal swab of the mouth – no blood draw required.
  • Second generation IVD assay with 100% overall accuracy and >99% precision.
  • Our laboratory results are available 3-5 days following receipt of the sample at Molecular™.

Thrombophilia Screening

  • Thrombophilia is a condition where the blood has an increased tendency to form clots.
  • Our test assesses the risk of clinical complications associated with thrombophilia in women during pregnancy.
  • Assesses the effectiveness of prophylactic treatments in preventing venous thromboembolism (VTE) and adverse pregnancy outcomes in women with thrombophilia during pregnancy.
  • Our Thrombophilia panel tests for:
    • Factor V Leiden (F5)
    • Methylenetetrahydrofolate Reductase (MTHFR)
    • Coagulation Factor II (F2)
Ultrasound baby.